My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 143

    1.

    Inhibition of GSK-3 selectively reduces glucose-6-phosphatase and phosphatase and phosphoenolypyruvate carboxykinase gene expression.

    Lochhead PA, Coghlan M, Rice SQ, Sutherland C.

    Diabetes. 2001 May;50(5):937-46.PMID: 11334436 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Antagonistic effects of phorbol esters on insulin regulation of insulin-like growth factor-binding protein-1 (IGFBP-1) but not glucose-6-phosphatase gene expression.

    Patel S, Lochhead PA, Rena G, Sutherland C.

    Biochem J. 2001 Nov 1;359(Pt 3):611-9.PMID: 11672436 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Regulation of glucose-6-phosphatase gene expression by protein kinase Balpha and the forkhead transcription factor FKHR. Evidence for insulin response unit-dependent and -independent effects of insulin on promoter activity.

    Schmoll D, Walker KS, Alessi DR, Grempler R, Burchell A, Guo S, Walther R, Unterman TG.

    J Biol Chem. 2000 Nov 17;275(46):36324-33.PMID: 10960473 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Glycogen synthase kinase-3 regulates IGFBP-1 gene transcription through the thymine-rich insulin response element.

    Finlay D, Patel S, Dickson LM, Shpiro N, Marquez R, Rhodes CJ, Sutherland C.

    BMC Mol Biol. 2004 Sep 6;5:15.PMID: 15350195 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Insulin and IGF-1 stimulate the beta-catenin pathway through two signalling cascades involving GSK-3beta inhibition and Ras activation.

    Desbois-Mouthon C, Cadoret A, Blivet-Van Eggelpoël MJ, Bertrand F, Cherqui G, Perret C, Capeau J.

    Oncogene. 2001 Jan 11;20(2):252-9.PMID: 11313952 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Opposing actions of phosphatidylinositol 3-kinase and glycogen synthase kinase-3beta in the regulation of HSF-1 activity.

    Bijur GN, Jope RS.

    J Neurochem. 2000 Dec;75(6):2401-8.PMID: 11080191 [PubMed - indexed for MEDLINE]Related articles

    7.

    Differential regulation of endogenous glucose-6-phosphatase and phosphoenolpyruvate carboxykinase gene expression by the forkhead transcription factor FKHR in H4IIE-hepatoma cells.

    Barthel A, Schmoll D, Krüger KD, Bahrenberg G, Walther R, Roth RA, Joost HG.

    Biochem Biophys Res Commun. 2001 Jul 27;285(4):897-902.PMID: 11467835 [PubMed - indexed for MEDLINE]Related articles

    8.

    Molecular mechanisms of insulin resistance in IRS-2-deficient hepatocytes.

    Valverde AM, Burks DJ, Fabregat I, Fisher TL, Carretero J, White MF, Benito M.

    Diabetes. 2003 Sep;52(9):2239-48.PMID: 12941762 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Regulation of the versican promoter by the beta-catenin-T-cell factor complex in vascular smooth muscle cells.

    Rahmani M, Read JT, Carthy JM, McDonald PC, Wong BW, Esfandiarei M, Si X, Luo Z, Luo H, Rennie PS, McManus BM.

    J Biol Chem. 2005 Apr 1;280(13):13019-28. Epub 2005 Jan 24.PMID: 15668231 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    The role of glycogen synthase kinase 3beta in insulin-stimulated glucose metabolism.

    Summers SA, Kao AW, Kohn AD, Backus GS, Roth RA, Pessin JE, Birnbaum MJ.

    J Biol Chem. 1999 Jun 18;274(25):17934-40.PMID: 10364240 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Dominant negative forms of Akt (protein kinase B) and atypical protein kinase Clambda do not prevent insulin inhibition of phosphoenolpyruvate carboxykinase gene transcription.

    Kotani K, Ogawa W, Hino Y, Kitamura T, Ueno H, Sano W, Sutherland C, Granner DK, Kasuga M.

    J Biol Chem. 1999 Jul 23;274(30):21305-12.PMID: 10409689 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Insulin regulation of phosphoenolpyruvate carboxykinase gene expression does not require activation of the Ras/mitogen-activated protein kinase signaling pathway.

    Gabbay RA, Sutherland C, Gnudi L, Kahn BB, O'Brien RM, Granner DK, Flier JS.

    J Biol Chem. 1996 Jan 26;271(4):1890-7.PMID: 8567635 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription.

    Coghlan MP, Culbert AA, Cross DA, Corcoran SL, Yates JW, Pearce NJ, Rausch OL, Murphy GJ, Carter PS, Roxbee Cox L, Mills D, Brown MJ, Haigh D, Ward RW, Smith DG, Murray KJ, Reith AD, Holder JC.

    Chem Biol. 2000 Oct;7(10):793-803.PMID: 11033082 [PubMed - indexed for MEDLINE]Related articles

    14.

    Growth hormone regulates phosphorylation and function of CCAAT/enhancer-binding protein beta by modulating Akt and glycogen synthase kinase-3.

    Piwien-Pilipuk G, Van Mater D, Ross SE, MacDougald OA, Schwartz J.

    J Biol Chem. 2001 Jun 1;276(22):19664-71. Epub 2001 Mar 13.PMID: 11278638 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    The B cell antigen receptor regulates the transcriptional activator beta-catenin via protein kinase C-mediated inhibition of glycogen synthase kinase-3.

    Christian SL, Sims PV, Gold MR.

    J Immunol. 2002 Jul 15;169(2):758-69.PMID: 12097378 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Reciprocal regulation of glycogen phosphorylase and glycogen synthase by insulin involving phosphatidylinositol-3 kinase and protein phosphatase-1 in HepG2 cells.

    Syed NA, Khandelwal RL.

    Mol Cell Biochem. 2000 Aug;211(1-2):123-36.PMID: 11055555 [PubMed - indexed for MEDLINE]Related articles

    17.

    GSK-3beta negatively regulates skeletal myotube hypertrophy.

    Vyas DR, Spangenburg EE, Abraha TW, Childs TE, Booth FW.

    Am J Physiol Cell Physiol. 2002 Aug;283(2):C545-51.PMID: 12107064 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Phosphatidylinositol 3-kinase and Ras/mitogen-activated protein kinase signaling pathways are required for the regulation of 5-aminolevulinate synthase gene expression by insulin.

    Scassa ME, Guberman AS, Varone CL, Cánepa ET.

    Exp Cell Res. 2001 Dec 10;271(2):201-13.PMID: 11716532 [PubMed - indexed for MEDLINE]Related articles

    19.

    Convergence of multiple signaling cascades at glycogen synthase kinase 3: Edg receptor-mediated phosphorylation and inactivation by lysophosphatidic acid through a protein kinase C-dependent intracellular pathway.

    Fang X, Yu S, Tanyi JL, Lu Y, Woodgett JR, Mills GB.

    Mol Cell Biol. 2002 Apr;22(7):2099-110.PMID: 11884598 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Protein breakdown in muscle from burned rats is blocked by insulin-like growth factor i and glycogen synthase kinase-3beta inhibitors.

    Fang CH, Li BG, James JH, King JK, Evenson AR, Warden GD, Hasselgren PO.

    Endocrinology. 2005 Jul;146(7):3141-9. Epub 2005 Mar 31.PMID: 15802492 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity